These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 71882)

  • 21. [Short and long term behaviour of pleural effusion cultures. (Report of 200 cases) (author's transl)].
    Mouriquand J; Mouriquand C; Petitpas E; Mermet MA; Augusseau S; Paramelle B
    Pathol Biol (Paris); 1977 Jan; 25(1):15-21. PubMed ID: 322031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of morphometric methods in cytologic diagnostics: differentiation between mesothelial cells, mesothelioma cells and metastatic adenocarcinoma cells in pleural effusions with special emphasis on chromatin texture.
    Oberholzer M; Ettlin R; Christen H; Gschwind R; Buser M; Rösel F; Lötscher R; Dalquen P
    Anal Cell Pathol; 1991 Jan; 3(1):25-42. PubMed ID: 2001333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of argyrophilic nucleolar organiser regions in pleural and peritoneal effusions.
    Khan SA; Chaudhry NA; Khalid AW; Akhtar GN; Ibne-Rasa SN
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):412-5. PubMed ID: 16787619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the nucleolar size and density in human early granulocytic progenitors, myeloblasts.
    Smetana K; Klamová H; Mikulenková D; Pluskalová M; Hrkal Z
    Eur J Histochem; 2006; 50(2):119-24. PubMed ID: 16864122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment.
    Monti G; Jaurand MC; Monnet I; Chretien P; Saint-Etienne L; Zeng L; Portier A; Devillier P; Galanaud P; Bignon J
    Cancer Res; 1994 Aug; 54(16):4419-23. PubMed ID: 8044791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-malignant cells in pleural fluid].
    Zsiray M; Lukács J; Appel J; Lantos A; Szondy K
    Orv Hetil; 1995 Jan; 136(1):27-30. PubMed ID: 7845663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura.
    Ramael M; Van den Bossche J; Buysse C; Deblier I; Segers K; Van Marck E
    Histol Histopathol; 1995 Jul; 10(3):639-43. PubMed ID: 7579812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of impact of EMCV replication on the nuclear apparatus of NIH 3T3 and HEp-2 cells.
    Karalyan ZA; Jaghatspanyan NG; Gasparyan MH; Hakobyan LA; Abroyan LO; Ter-Pogossyan ZR; Kamalyan LA; Karalova EM
    Cell Biol Int; 2005 Jul; 29(7):586-92. PubMed ID: 15996489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interferometric analysis of nucleoli in cultured mesothelial cells.
    Blumenstein R; Amenta PS
    Anat Rec; 1981 Sep; 201(1):13-21. PubMed ID: 7030143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid.
    Kwee WS; Veldhuizen RW; Alons CA; Morawetz F; Boon ME
    Acta Cytol; 1982; 26(4):401-6. PubMed ID: 6957089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma.
    Lindholm PM; Soini Y; Myllärniemi M; Knuutila S; Heikinheimo M; Kinnula VL; Salmenkivi K
    J Clin Pathol; 2009 Apr; 62(4):339-44. PubMed ID: 19060016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytomorphologic concomitant reactions in malignant pleural effusions].
    Greis M; Atay Z
    Pneumologie; 1990 Feb; 44 Suppl 1():263-4. PubMed ID: 1694998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders.
    Werle B; Sauckel K; Nathanson CM; Bjarnadottir M; Spiess E; Ebert W; Abrahamson M
    Biol Chem; 2003 Feb; 384(2):281-7. PubMed ID: 12675521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleolar organizer regions in mesothelial proliferations.
    Ramael M; Van den Bossche J; Buysse C; Van Marck E
    J Pathol; 1992 Aug; 167(4):435. PubMed ID: 1403363
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.